Effect of Body Composition on Outcomes in Patients with Hepatocellular Carcinoma Undergoing Radiotherapy: A Retrospective Study
- 11 May 2022
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 74 (9) , 3302-3311
Abstract
Computed tomography (CT)–assessed body composition is considered a novel prognostic factor for cancer patients. Owing to the need for new prognostic markers for hepatocellular carcinoma (HCC) patients undergoing radiotherapy, we investigated the impact of body composition on outcomes in this patient population. We retrospectively evaluated 109 HCC patients receiving radiotherapy. The skeletal muscle index, subcutaneous adipose tissue index (SATI), and visceral adipose tissue index within 1 mo, before radiotherapy were assessed based on a single CT image slice at the level of the third lumbar (L3) vertebra. The impact of body composition parameters on progression-free survival (PFS) and overall survival (OS) was assessed. Overall, 62 (56.9%) patients died, and 47 (43.1%) patients experienced recurrence during a median follow-up period of 20.5 mo. Multivariate analysis revealed that SATI was an independent prognostic factor for both PFS (hazard ratio [HR] 0.542, P = 0.025) and OS (HR 0.385, P = 0.005). Patients with high SATI (n = 43) had significantly better PFS (P = 0.0093) and OS (P = 0.032) than those with low SATI (n = 66). CT-assessed SATI is an independent prognostic factor in HCC patients receiving radiotherapy. Further validation is warranted to determine whether this finding can be translated into other study populations.Keywords
Funding Information
- National Natural Science Foundation of China (81903257)
This publication has 42 references indexed in Scilit:
- High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingEuropean Journal of Cancer, 2015
- Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitorsDigestive and Liver Disease, 2015
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?Diabetes Care, 2009
- Conformal radiotherapy for hepatocellular carcinomaCritical Reviews in Oncology/Hematology, 2008
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- Beneficial Effects of Subcutaneous Fat Transplantation on MetabolismCell Metabolism, 2008
- Abdominal Visceral and Subcutaneous Adipose Tissue CompartmentsCirculation, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006